![Peter Colabuono](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Colabuono
Directeur Général chez
Ariagen, Inc.
Fortune : - $ au 31/05/2026
Profil
Peter Colabuono is currently Chief Executive Officer at Ariagen, Inc., Director at Solve Therapeutics, Inc., Firefly Bio, Inc., and ConjugateBio, Inc., and Principal at Decheng Capital LLC since 2016.
Former positions include Senior Director-Business Development at Ironwood Pharmaceuticals, Inc. (2015–2016), Director at Whitehawk Therapeutics, Inc., Director at Equillium, Inc. (2024–2026), Independent Director at Checkmate Pharmaceuticals, Inc. (2019–2022), VP-Business Development & Managed Care at Silvergate Pharmaceuticals, Inc. (2011–2014), Associate at Frazier Management LLC (2010–2011), and Member at Cowen Group, Inc. and Morgan Stanley & Co. LLC.
Education includes an undergraduate degree from Dartmouth College, conferred in 2004.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC. -.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Peter Colabuono
| Sociétés | Poste | Début |
|---|---|---|
Decheng Capital LLC
 Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Private Equity Investor | 01/10/2016 |
Ariagen, Inc.
 Ariagen, Inc. BiotechnologyHealth Technology Develops preclinical stage therapeutic drug products | Directeur Général | - |
Conjugatebio, Inc.
 Conjugatebio, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Firefly Bio, Inc.
 Firefly Bio, Inc. BiotechnologyHealth Technology Engages in development and discovery degrader antibody conjugates | Directeur/Membre du Conseil | - |
Solve Therapeutics, Inc.
 Solve Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugates for treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Colabuono
| Sociétés | Poste | Fin |
|---|---|---|
| EQUILLIUM, INC. | Directeur/Membre du Conseil | 28/05/2026 |
| CHECKMATE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 31/05/2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2016 |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/05/2014 |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Colabuono
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Cowen Group, Inc. /Old/
 Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Provides investment banking services | Finance |
Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Finance |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Ariagen, Inc.
Ariagen, Inc. BiotechnologyHealth Technology Develops preclinical stage therapeutic drug products | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Solve Therapeutics, Inc.
Solve Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugates for treatment of cancer | Health Technology |
Firefly Bio, Inc.
Firefly Bio, Inc. BiotechnologyHealth Technology Engages in development and discovery degrader antibody conjugates | Health Technology |
Conjugatebio, Inc.
Conjugatebio, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
